CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 55 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,118 | +22.2% | 17,082 | +30.2% | 0.00% | – |
| Q4 2021 | $32,000 | -67.0% | 13,118 | -34.3% | 0.00% | – |
| Q3 2021 | $97,000 | +34.7% | 19,954 | -24.5% | 0.00% | -100.0% |
| Q2 2020 | $72,000 | +38.5% | 26,418 | +8.1% | 0.00% | 0.0% |
| Q1 2020 | $52,000 | -71.7% | 24,436 | -46.6% | 0.00% | -50.0% |
| Q1 2019 | $184,000 | -31.9% | 45,785 | -37.7% | 0.00% | -33.3% |
| Q4 2018 | $270,000 | -38.1% | 73,454 | +44.5% | 0.00% | -40.0% |
| Q3 2018 | $436,000 | +164.2% | 50,824 | +237.6% | 0.01% | +150.0% |
| Q2 2018 | $165,000 | +7.1% | 15,053 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $154,000 | – | 13,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,910,000 | 1.84% |
| Novo Holdings A/S | 2,927,560 | $7,963,000 | 0.51% |
| Puissance Capital Management LP | 38,010 | $103,000 | 0.44% |
| CHI Advisors LLC | 364,132 | $990,000 | 0.39% |
| BVF INC/IL | 1,742,112 | $4,739,000 | 0.29% |
| Orbimed Advisors | 6,767,584 | $18,408,000 | 0.26% |
| EcoR1 Capital, LLC | 737,612 | $2,006,000 | 0.15% |
| Hikari Power Ltd | 60,959 | $166,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $364,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,192,742 | $3,244,000 | 0.00% |